| abstract |
Systemic diseases of cats such as dilated cardiomyopathy (DCM), mitral regurgitation (MI), hypertrophic cardiomyopathy (HCM) and other acquired or congenital heart diseases Providing new preventive or therapeutic agents for diseases, systemic hypertension such as hypertension associated with kidney disease, chronic kidney disease and other vascular diseases, metabolic diseases such as diabetes mellitus. A pharmaceutical composition comprising an angiotensin II receptor 1 (AT-1) antagonist (sultan). A therapeutically effective amount of an AT-1 antagonist (sultan) is about 0.01 to about 5.0 mg / kg body weight. [Selection figure] None |